0.2757
6.54%
-0.0193
Handel nachbörslich:
.29
0.0143
+5.19%
Finanzdaten der Vincerx Pharma Inc-Aktie (VINC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
35.15%
7.478
|
5.533 | 10.32 | 11.66 | 15.10 |
Operating Income/Loss |
35.15%
-7.478
|
-5.533 | -10.32 | -11.66 | -15.10 |
Nonoperating Income/Loss |
949.23%
-4.951
|
0.583 | 0.602 | 0.509 | 0.758 |
Income/Loss From Continuing Operations Before Tax |
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
Income/Loss From Continuing Operations After Tax |
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
Net Income/Loss
|
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
82,208%
0.0214
|
0.000026 | 0.0213 | 0.0213 | 0.0212 |
Diluted Average Shares |
82,208%
0.0214
|
0.000026 | 0.0213 | 0.0213 | 0.0212 |
Basic Earnings Per Share |
152.17%
-0.58
|
-0.23 | -0.46 | -0.52 | -0.68 |
Diluted Earnings Per Share |
152.17%
-0.58
|
-0.23 | -0.46 | -0.52 | -0.68 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):